Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.79564 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.63626 | 92 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.39796 | 91 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.50836 | 91 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.50294 | 91 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.55173 | 93 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.02907 | 90 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.33899 | 91 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.2264 | 90 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.52957 | 91 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.9381 | 89 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.44247 | 91 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.43811 | 91 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.21884 | 90 |